vs
Side-by-side financial comparison of SWK Holdings Corp (SWKH) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.
SWK Holdings Corp is the larger business by last-quarter revenue ($8.7M vs $5.5M, roughly 1.6× Taysha Gene Therapies, Inc.). On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs -29.7%). Over the past eight quarters, Taysha Gene Therapies, Inc.'s revenue compounded faster (26.8% CAGR vs -12.5%).
SWK Holdings Corp is a specialty finance firm focused on the healthcare and life sciences sectors. It provides tailored financing solutions including royalty monetization, structured debt, and asset-backed lending to biotech, pharmaceutical, medical device and diagnostic companies, with its core market centered in North America.
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.
SWKH vs TSHA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.7M | $5.5M |
| Net Profit | $-19.4M | $-27.9M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | -516.0% |
| Net Margin | — | -507.8% |
| Revenue YoY | -29.7% | 171.3% |
| Net Profit YoY | -430.2% | -48.3% |
| EPS (diluted) | $-1.59 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.7M | $5.5M | ||
| Q3 25 | $10.9M | $0 | ||
| Q2 25 | $10.1M | $2.0M | ||
| Q1 25 | $11.8M | $2.3M | ||
| Q4 24 | $12.4M | $2.0M | ||
| Q3 24 | $10.4M | $1.8M | ||
| Q2 24 | $10.8M | $1.1M | ||
| Q1 24 | $11.4M | $3.4M |
| Q4 25 | $-19.4M | $-27.9M | ||
| Q3 25 | $8.8M | $-32.7M | ||
| Q2 25 | $3.5M | $-26.9M | ||
| Q1 25 | $4.5M | $-21.5M | ||
| Q4 24 | $5.9M | $-18.8M | ||
| Q3 24 | $3.5M | $-25.5M | ||
| Q2 24 | $3.7M | $-20.9M | ||
| Q1 24 | $468.0K | $-24.1M |
| Q4 25 | 9.9% | -516.0% | ||
| Q3 25 | 61.3% | — | ||
| Q2 25 | 46.1% | -1347.1% | ||
| Q1 25 | 68.6% | -930.5% | ||
| Q4 24 | 44.7% | -985.8% | ||
| Q3 24 | 39.2% | -1448.4% | ||
| Q2 24 | 8.3% | -1915.4% | ||
| Q1 24 | 9.5% | -713.3% |
| Q4 25 | — | -507.8% | ||
| Q3 25 | 80.7% | — | ||
| Q2 25 | 35.2% | -1353.6% | ||
| Q1 25 | 38.4% | -935.2% | ||
| Q4 24 | 47.5% | -929.0% | ||
| Q3 24 | 33.3% | -1427.5% | ||
| Q2 24 | 33.9% | -1882.0% | ||
| Q1 24 | 4.1% | -705.4% |
| Q4 25 | $-1.59 | $-0.08 | ||
| Q3 25 | $0.72 | $-0.09 | ||
| Q2 25 | $0.29 | $-0.09 | ||
| Q1 25 | $0.37 | $-0.08 | ||
| Q4 24 | $0.47 | $-0.07 | ||
| Q3 24 | $0.28 | $-0.10 | ||
| Q2 24 | $0.30 | $-0.09 | ||
| Q1 24 | $0.04 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $42.8M | $319.8M |
| Total DebtLower is stronger | $33.0M | — |
| Stockholders' EquityBook value | $235.1M | $246.9M |
| Total Assets | $272.4M | $343.3M |
| Debt / EquityLower = less leverage | 0.14× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $42.8M | $319.8M | ||
| Q3 25 | $10.2M | $297.3M | ||
| Q2 25 | $8.0M | $312.8M | ||
| Q1 25 | $29.8M | $116.6M | ||
| Q4 24 | $5.9M | $139.0M | ||
| Q3 24 | $17.2M | $157.7M | ||
| Q2 24 | $5.5M | $172.7M | ||
| Q1 24 | $5.5M | $124.0M |
| Q4 25 | $33.0M | — | ||
| Q3 25 | $33.0M | — | ||
| Q2 25 | $33.0M | — | ||
| Q1 25 | $33.0M | — | ||
| Q4 24 | $33.0M | — | ||
| Q3 24 | $33.0M | — | ||
| Q2 24 | $33.0M | — | ||
| Q1 24 | $33.0M | — |
| Q4 25 | $235.1M | $246.9M | ||
| Q3 25 | $254.2M | $219.0M | ||
| Q2 25 | $246.5M | $248.7M | ||
| Q1 25 | $292.7M | $55.1M | ||
| Q4 24 | $288.7M | $71.5M | ||
| Q3 24 | $283.4M | $88.8M | ||
| Q2 24 | $282.8M | $108.9M | ||
| Q1 24 | $279.9M | $53.8M |
| Q4 25 | $272.4M | $343.3M | ||
| Q3 25 | $289.4M | $316.6M | ||
| Q2 25 | $285.7M | $333.3M | ||
| Q1 25 | $331.3M | $138.4M | ||
| Q4 24 | $332.2M | $160.4M | ||
| Q3 24 | $321.3M | $180.2M | ||
| Q2 24 | $321.0M | $200.4M | ||
| Q1 24 | $322.0M | $153.0M |
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.13× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | 0.11× | — | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.12× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $27.3M | $-26.7M |
| Free Cash FlowOCF − Capex | $26.8M | — |
| FCF MarginFCF / Revenue | 308.1% | — |
| Capex IntensityCapex / Revenue | 5.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.3M | $-26.7M | ||
| Q3 25 | $906.0K | $-24.2M | ||
| Q2 25 | $7.8M | $-20.2M | ||
| Q1 25 | $8.3M | $-22.0M | ||
| Q4 24 | $23.0M | $-18.3M | ||
| Q3 24 | $6.3M | $-21.6M | ||
| Q2 24 | $5.4M | $-21.5M | ||
| Q1 24 | $4.4M | $-19.8M |
| Q4 25 | $26.8M | — | ||
| Q3 25 | $557.0K | $-24.3M | ||
| Q2 25 | $7.7M | — | ||
| Q1 25 | $8.2M | — | ||
| Q4 24 | $22.9M | $-18.3M | ||
| Q3 24 | $6.3M | $-21.6M | ||
| Q2 24 | $5.4M | $-21.7M | ||
| Q1 24 | — | $-19.9M |
| Q4 25 | 308.1% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | 77.0% | — | ||
| Q1 25 | 69.1% | — | ||
| Q4 24 | 185.3% | -905.5% | ||
| Q3 24 | 60.4% | -1210.9% | ||
| Q2 24 | 49.7% | -1951.9% | ||
| Q1 24 | — | -584.5% |
| Q4 25 | 5.9% | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 1.1% | 0.1% | ||
| Q3 24 | 0.3% | 2.0% | ||
| Q2 24 | 0.2% | 18.1% | ||
| Q1 24 | 0.0% | 4.1% |
| Q4 25 | — | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 1.82× | — | ||
| Q4 24 | 3.93× | — | ||
| Q3 24 | 1.82× | — | ||
| Q2 24 | 1.47× | — | ||
| Q1 24 | 9.47× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
TSHA
Segment breakdown not available.
